[Xeroderma pigmentosum. A case treated with a beta-carotene-canthaxanthin combination and aromatic retinoid].
D016644:Canthaxanthin; D002280:Basal Cell Carcinoma / Q000517:prevention & control; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control; D002338:Carotenoids / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005050:Etretinate / Q000008:administration & dosage*; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D008297:Male; D012878:Skin Neoplasms / Q000517:prevention & control*; D014983:Xeroderma Pigmentosum / Q000188:drug therapy*; D019207:beta Carotene
D004338:Drug Combinations; D019207:beta Carotene; D002338:Carotenoids; D016644:Canthaxanthin; C041347:phenoro; D005050:Etretinate
Xeroderma pigmentosum. Un cas traité par l'association bêtacarotène-canthaxanthine et rétinoïde aromatique.